Show
Sort by
-
- Journal Article
- A1
- open access
Off-patent biologicals and biosimilars tendering in Europe : a proposal towards more sustainable practices
-
- Book Chapter
- open access
Biobanking across Europe post-GDPR : a deliberately fragmented landscape
-
- Book Chapter
- open access
An overview of Belgian legislation applicable to biobank research and its interplay with data protection rules
-
- Journal Article
- A2
- open access
Developing a methodology to balance benefit-sharing : application in the context of biodiversity beyond national jurisdiction
-
- Journal Article
- A1
- open access
Policies for biosimilar uptake in Europe : an overview
-
Public views on genetics and genetic testing : a survey of the general public in Belgium
-
Chemotherapy drug shortages in paediatric oncology : a 14-year single-centre experience in Belgium
-
A bacteriophage journey at the European Medicines Agency
-
- Journal Article
- A1
- open access
Quality and safety requirements for sustainable phage therapy products
-
- Journal Article
- A1
- open access
'Trust is not something you can reclaim easily' : patenting in the field of direct-to-consumer genetic testing
-
Key issues in phage therapy: a report of a dedicated workshop at the viruses of microbes II meeting
-
- Journal Article
- A1
- open access
Introducing yesterday's phage therapy in today's medicine
-
The phage therapy paradigm: prêt-à-porter or sur-mesure?
-
A subfamily of acidic alpha-K+ toxins